Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0018787,
umls-concept:C0022661,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0085580,
umls-concept:C0086418,
umls-concept:C0102586,
umls-concept:C0205307,
umls-concept:C0332835,
umls-concept:C0441889,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1707455,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2709270
|
pubmed:issue |
5
|
pubmed:dateCreated |
1990-1-11
|
pubmed:abstractText |
1. Plasma levels of immunoreactive N-terminal pro-atrial natriuretic peptide (N-terminal ANP) have been measured in 25 normal subjects, 29 patients with essential hypertension, six cardiac transplant recipients, seven patients with dialysis-independent chronic renal failure and 11 patients with haemodialysis-dependent chronic renal failure. Plasma was extracted on Sep-Pak cartridges and N-terminal ANP immunoreactivity was measured using an antibody directed against pro-ANP (1-30). 2. Plasma levels of N-terminal ANP (means +/- SEM) were 235.3 +/- 19.2 pg/ml in normal subjects and were significantly raised in patients with essential hypertension (363.6 +/- 36.3 pg/ml), in cardiac transplant recipients (1240.0 +/- 196.2 pg/ml), in patients with chronic renal failure not requiring dialysis (1636.6 +/- 488.4 pg/ml) and patients with chronic renal failure on maintenance haemodialysis (10336.1 +/- 2043.7 pg/ml). 3. There were positive and significant correlations between the plasma levels of N-terminal ANP and alpha-human ANP (alpha-hANP) with individual correlation coefficients of 0.68 within the normal subjects, 0.47 in patients with essential hypertension, 0.78 in patients with dialysis-independent chronic renal failure and 0.68 in patients with haemodialysis-dependent chronic renal failure (P less than 0.05 in every case).(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0143-5221
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
573-9
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:2531055-Adolescent,
pubmed-meshheading:2531055-Adult,
pubmed-meshheading:2531055-Aged,
pubmed-meshheading:2531055-Atrial Natriuretic Factor,
pubmed-meshheading:2531055-Chromatography, Gel,
pubmed-meshheading:2531055-Female,
pubmed-meshheading:2531055-Heart Transplantation,
pubmed-meshheading:2531055-Humans,
pubmed-meshheading:2531055-Hypertension,
pubmed-meshheading:2531055-Kidney Failure, Chronic,
pubmed-meshheading:2531055-Male,
pubmed-meshheading:2531055-Middle Aged,
pubmed-meshheading:2531055-Natriuresis,
pubmed-meshheading:2531055-Peptide Fragments,
pubmed-meshheading:2531055-Protein Precursors,
pubmed-meshheading:2531055-Reference Values
|
pubmed:year |
1989
|
pubmed:articleTitle |
Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure.
|
pubmed:affiliation |
Department of Medicine, Charing Cross and Westminster Medical School, London.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|